TherapeuticsMD, Inc. (TXMD)
NASDAQ: TXMD · Real-Time Price · USD
2.220
0.00 (0.00%)
At close: Aug 28, 2026, 4:00 PM EDT
2.213
-0.007 (-0.30%)
After-hours: Aug 28, 2026, 5:33 PM EDT
TherapeuticsMD Employees
TherapeuticsMD had 1 employees as of June 30, 2026. The number of employees did not change compared to the same quarter last year.
Employees
1
Change
n/a
Growth
n/a
Revenue / Employee
$3,270,000
Profits / Employee
-$217,000
Market Cap
25.70M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 1 | 0 | - |
| Mar 31, 2026 | 1 | 0 | - |
| Dec 31, 2025 | 1 | 0 | - |
| Sep 30, 2025 | 1 | 0 | - |
| Jun 30, 2025 | 1 | 0 | - |
| Mar 31, 2025 | 1 | 0 | - |
| Dec 31, 2024 | 1 | 0 | - |
| Sep 30, 2024 | 1 | 0 | - |
| Jun 30, 2024 | 1 | 0 | - |
| Mar 31, 2024 | 1 | 0 | - |
| Dec 31, 2023 | 1 | 0 | - |
| Sep 30, 2023 | 1 | 0 | - |
| Jun 30, 2023 | 1 | - | - |
| Mar 31, 2023 | 1 | -415 | -99.76% |
| Dec 31, 2022 | 1 | -415 | -99.76% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| InterCure | 285 |
| China Pharma Holdings | 215 |
| Rockwell Medical | 157 |
| Biofrontera | 94 |
| Aytu BioPharma | 83 |
| BioXcel Therapeutics | 29 |
| SCYNEXIS | 18 |
| Incannex Healthcare | 12 |
TXMD News
- 17 days ago - TherapeuticsMD Announces Second Quarter 2026 Financial Results - Business Wire
- 17 days ago - TherapeuticsMD Earnings release: Q2 2026 - Filings
- 17 days ago - TherapeuticsMD Quarterly report: Q2 2026 - Filings
- 3 months ago - TherapeuticsMD reports Q1 EPS 1c vs. (6c) last year - TheFly
- 3 months ago - TherapeuticsMD Announces First Quarter 2026 Financial Results - Business Wire
- 3 months ago - TherapeuticsMD Earnings release: Q1 2026 - Filings
- 3 months ago - TherapeuticsMD Quarterly report: Q1 2026 - Filings
- 5 months ago - TherapeuticsMD reports FY25 EPS (6c) vs. (20c) last year - TheFly